J. Martin Carroll - Insider Trading & Ownership

Location
C/O Catalent, Inc., 14 Schoolhouse Road, Somerset, NJ
Summary
The estimated net worth of J. Martin Carroll is at least $370K dollars as of June 2, 2025. J. Martin Carroll is the Director of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $239K. J. Martin Carroll is the Director of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $131K.
Signature
/s/ Sheldon L. Koenig, by power of attorney
All Insider Reports
All Insider Reports

Ownership of J. Martin Carroll

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TXMD TherapeuticsMD, Inc. Director $239K Aug 10, 2021
ESPR Esperion Therapeutics, Inc. Director $131K May 29, 2025
CTLT Catalent, Inc. Director $0 Dec 18, 2024
MNKTQ Mallinckrodt plc Director Jun 16, 2022

Insider Transactions Reported by J. Martin Carroll:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.